Abstract
Tumors occur in various locations of ocular structures. They may be benign or malignant. At times the tumors are managed non-surgically using pharmacological agents. Many times chemotherapy is used as an adjunct to surgical excision and enucleation. The prognosis of the ocular tumours solely depends on the early diagnosis, nature and the location of the tumor. This chapter extensively discusses about the clinical features, classification, diagnostic criteria for the ocular tumors and neoplasm, chemotherapeutic agents used in orbital and ocular tumors of childhood like retinoblastoma, drugs used for the treatment for the surface neoplasm and the underlying pharmacological modalities.
Keywords
- Ocular Surface
- Anterior Segment Optical Coherence Tomography
- Ocular Surface Squamous Neoplasia
- Ocular Tumor
- Hereditary Retinoblastoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aldave AJ, Nguyen A. Ocular surface toxicity associated with topical interferon α-2b. Br J Ophthalmol 2007;91:1087–8.
Banavali S. Evidence based management for retinoblastoma. Indian Journal of Medical and Pediatric Oncology 2004;25:35–45.
Basti S, Mascai MS. Ocular surface squamous neoplasia. Cornea 2003;22(7):687–704.
Bazhanova ED. Participation of interferon-alpha in regulation of apoptosis. J Evol Biochem Phys 2005;41(2):127–33.
Bekisz J, Baron S, Balinsky C, Morrow A, dan Zoon KC. Antiproliferative properties of type I and type II interferon. Pharmaceuticals (Basel) 2010;3(4):994–1015.
Blumenkranz MS, Claflin A, Hajek AS. Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch Ophthalmol 1984;102(4):598–604.
Boehm MD, Huang AJ. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology 2004;111:1755–61.
Boese E, Rogers GM, Kitzmann AS. A very unusual case of ocular surface squamous neoplasia. EyeRounds.org. 14 Feb 2013. Available from: http://EyeRounds.org/cases/163-OSSN.htm. Accessed 22 June 2015.
Carreira H, Coutinho F, Carrilho C, Lunet N. HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis. Br J Cancer 2013;109(7):1981–8.
Chabner BA, Bertino J, Cleary J, et al. Cytoxic agents. In: Brunton LL (ed). The pharmacological basis of therapeutics. The McGraw-Hill Companies, Inc. 12th ed, 2011:1665–755.
Chantada GL, Guitter MR, Fandino AC, Raslawski EC, de Davila MT, Vaiani E, et al. Treatment results in patients with RB and invasion to cut end of ON. Pediatr Blood cancer 2009;52:218–22.
Chawla B, Jain A, Azad R. Conservative treatment modalities in retinoblastoma. Indian J Ophthalmol 2013;61(9):479–85. doi: 10.4103/0301-4738.119424. Review. PMID: 24104705
Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, Pandey RM. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol 2015 Jun 10. pii: bjophthalmol-2015-306672. doi:10.1136/bjophthalmol-2015-306672. [Epub ahead of print] PMID: 26061162
Chiariello M, Gomez E, Gutkind JS. Regulation of cyclin-dependent kinase (Cdk) 2 Thr-160 phosphorylation and activity by mitogen-activated protein kinase in late G1 phase. Biochem J. 2000;349(3):869–76.
Chu E, Sartorelli AC Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ (Eds). Basic and Clinical Pharmacology. New York, NY: McGraw-Hill Companies, Inc. 12th ed, 2012: 949–76.
Dimaras H, Kimani K, Dimba EAO, Gronsdah P, White A, Chan SL, Gallie BL. Retinoblastoma. Lancet 2012;379:1436–46.
Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994; 117:164–8.
Gichuhi S, Sagoo MS, Weiss HA, Burton MJ. Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health 2013;18(12):1424–43.
Gichuhi S, Sagoo MS, Ohnuma S, Burton MJ. Pathophysiology of ocular surface squamous neoplasia. Exp Eye Res 2014;129:172–82.
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59–67.
Guyer DR, Tiedeman J, Yannuzzi LA, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993;111:350–6.
Holcombe DJ, Lee GA. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia. Am J Ophthalmol 2006;142(4):568–71.
Hurwitz RL, Shields CL, Shields JA, Cheves-Barrios P, Gombos D, Hurwitz MY, Chintagumpala MM. Retinoblastoma. In: Pizzo PA, Poplack DG, editors. Principles and practices of pediatric oncology. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 809–37.
de Keizer RJ, de Wolff-Rouendaal D, van Delft JL. Topical application of 5-fluorouracil in premalignant lesions of cornea: conjunctiva and eyelid. Doc Ophthalmol 1986;64(1):31–42.
Kieval JZ, Karp CL, Abou Shousha M, Galor A, Hoffman RA, Dubovy SR, et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology 2012;119(3):481–6.
Kiire CA, Srinivasan S, Karp CL. Ocular surface squamous neoplasia. Int Ophthal Mol Clin 2010;50(3):35–46.
Kim JW, Abramson DH. Topical treatment options for conjunctival neoplasms. Clin Ophthalmol 2008;2(3):503–15.
Kruh GD. Lustrous insights into cisplatin accumulation: copper transporters. Clin Cancer Res 2003;9:5807–9.
Lee GA, Hirst LW. Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. Arch Ophthalmol 1992;110:525–7.
Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol 1995;39(6):429–50.
Linn Murphree A. Intraocular retinoblastoma: The case for a new group classification. Ophthalmol Clin North Am 2005;18:41–53.
Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol 1994;112(9):1145–6
Midena E, Boccato P, Angeli CD. Conjunctival squamous cell carcinoma treated with topical 5- fluorouracil. Arch Ophthalmol 1997;115(12):1600–1.
Midena E, Angeli CD, Valenti M, et al. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophthalmol 2000;84(3):268–72.
Nagaiah G, Stotler C, Orem J, Mwanda WO, Remicka SC. Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa. Curr Opin Oncol 2010;22(5):437–42.
Nemet AY, Sharma V, and Benger R. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C. Clin Exp Ophthalmol 2006;34:375–7.
Panda A, Pe’er J, Aggarwal A, et al. Effect of topical mitomycin C on corneal endothelium. Am J Ophthalmol 2008;145(4):635–8.
Papaioannou IT, Melachrinou MP, Drimtzias EG, Gartaganis SP. Corneal-conjunctival squamous cell carcinoma. Cornea 2008;27(8):957–8.
Parrozzani R, Lazzarini D, Alemany-Rubio E, Urban F, Midena E. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study. Br J Ophthalmol 2011;95(3):355–9. doi: 10.1136/bjo.2010.183244. Epub 2010 Aug 7.
Pe’er J. Ocular surface squamous neoplasia. Ophthalmol Clin North Am. 2005;18(1):1–13.
Pizzarello LD, Jakobiec FA. Bowen’s disease of the conjunctiva: a misnomer. In: Jakobiec FA, editor. Ocularand adnexal tumors. Birmingham: Aesculapius; 1978. p. 553–71.
Poothullil AM, Colby KA. Topical medical therapies for ocular surface tumors. Semin Ophthalmol 2006;21:161–9.
Purvin VA. Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 1995;113:1041–4.
Rodriguez-Galindo C. Chemotherapy management in retinoblastoma. In: Rodriguez-Galindo C, Wilson MW (eds). Retinoblastoma. Springer, New York. 1st ed. 2010:67–73.
Rudkin AK, Dodd T, Muecke JS. The differential diagnosis of localized amelanotic limbal lesions: a review of 162 consecutive excisions. Br J Ophthalmol 2011;95:350–4.
Rudkin AK, Muecke JS. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol 2011;95(7):947–50. doi:10.1136/bjo.2010.186171. Epub 2011 Jan 20.
Sepulveda R, Pe’er J, Midena E, Seregard S, Dua HS, Singh AD. Topical chemotherapy for ocular surface squamous neoplasia: current status. Br J Ophthalmol 2010;94(5):532–5. doi: 10.1136/bjo.2009.160820. Epub 2009 Sep 23. Review. PMID: 19776089
Shields CL, Shields JA, Baez KA, Cater JR, Potter P. Choroial invasion of RB: metastatic and clinical risk factors. Br J Ophthalmol 1993;77:544–8.
Shields JA, Shields CL. Pediatric ocular and periocular tumors. Pediatr Ann 2001;30:491–501.
Shields CL, Kaliki S, Kim HJ, Al-Dahmash S, Shah SU, Lally SE, Shields JA. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification. Cornea. 2013;32(3):248–56.
Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003;22(47):7265–79.
Sturges A, Butt AL, Lai JE, Chodosh J. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology 2008;115(8):1297–302, 1302.e1. doi: 10.1016/j.ophtha.2008.01.006. Epub 2008 Feb 21.
Tagliaferri P, Caraglia M, Budillon A, et al. New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer. Cancer Immunol Immunother 2005;54(1):1–10.
Tananuvat N, Lertprasertsuke N. Ocular Surface Squamous Neoplasia. In: Srivastava S, editor. Intraepithelial neoplasia. Publisher InTech. Published online 08 Feb 2012. Published in print edition February; 2012. www.intechopen.com. p. 35–62.
Tananuvat N, Lertprasertsuk N, Mahanupap P, Noppanakeepong P. Role of impression cytology in diagnosis of ocular surface neoplasia. Cornea 2008;27:269–74.
Tripathi KD. Chemotherapy of neoplastic diseases. In: Essentials of medical pharmacology. 6th ed. New Delhi: Jaypee Brothers Medical Publishers 2008; p. 819–34.
Vann RR, Karp CL. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia. Ophthalmology 1999;106:91–7.
Velpandian T, Saluja V, Ravi AK, Kumari SS, Mathur R, Biswas NR, Ghose S. Evaluation of the stability of extemporaneously prepared ophthalmic formulation of mitomycin C. J Ocul Pharmacol Ther. 2005;21(3):217–21.
Xu Y, Zhou Z, Xu Y, Wang M, Liu F, Qu H, et al. The clinical value of in vivo confocal microscopy for diagnosis of ocular surface squamous neoplasia. Eye (Lond) 2012;26(6):781–7.
Yeatts RP, Engelbrecht NE, Curry CD, et al. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. Ophthalmology 2000;107(12):2190–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chawla, B., Seth, R., Moksha, L. (2016). Chemotherapy for Ocular Cancers. In: Velpandian, T. (eds) Pharmacology of Ocular Therapeutics. Adis, Cham. https://doi.org/10.1007/978-3-319-25498-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-25498-2_12
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-25496-8
Online ISBN: 978-3-319-25498-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)